Table 1.
Variables | CN (n=14) | HAND (n=38) | CN vs HAND | CN vs ANI vs MND | |||
---|---|---|---|---|---|---|---|
ANI (n=17) | MND (n=21) | p-value (CN vs HAND; t-test) | Effect Size - Cohen’s d (CN vs HAND) | p-value (ANOVA) | Effect Size: overall, (CN vs ANI, CN vs MND, ANI vs MND) | ||
Demographics | |||||||
Hispanic ethnicity, n (%) | 57.1 | 56.3 | 66.7 | N/A | N/A | N/A | N/A |
Sex (f/m) | 0/14 | 7/10 | 2/19 | N/A | N/A | N/A | N/A |
Years of Education | 12.0 ± 2.09 | 12.36 ± 2.42 | 11.53 ± 3.02 | 0.79 | 0.03 | 0.75 | 0.25 (0.17, 0.00, 0.23) |
Years of Age | 37.3 ± 5.5 | 44 ± 9.0 | 45.9 ± 8.3 | 0.005** | 1.31 | 0.009** | 0.44 (0.32, 0.43, 0.10) |
HIV Disease Characteristics | |||||||
Duration on ART regimen (months) | 68.83 ± 48.05 | 75.74 ± 83.68 | 68.7 ± 57.93 | 0.95 | 0.25 | 0.82 | 0.05 (0.04, 0.004, 0.05) |
Plasma VL (log) | 4.3 ± 1.61 | 3.8 ± 1.55 | 4.2 ± 1.62 | 0.76 | 0.2 | 0.81 | 0.13 (0.12, 0.03, 0.10) |
CD4 count | 147.7 ± 239.01 | 142.8 ± 198.21 | 30.1 ± 35.81 | 0.33 | 0.32 | 0.12 | 0.31 (0.01, 0.26, 0.27) |
PMI (hours) | 6.5 ± 3.75 | 20.3 ± 21.1 | 9.6 ± 8.1 | 0.09 | 0.68 | 0.08 | 0.43 (0.40, 0.09, 0.34) |